Preterm Birth and PROM Testing Market Size, Share & Trends Analysis Report By Type (Pelvic Exam, Ferning, Nitazine, Pooling, Ultrasound, Uterine Monitoring, Biomarkers), And Segment Forecasts, 2019 - 2025

Published: Feb, 2019 | Pages: 111 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global preterm birth and prom testing market size is expected to reach USD 1.3 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 1.8% during the forecast period. Rising incidence of preterm births, increasing geographical reach by market players, high demand for effective diagnosis of preterm births, and advanced drug delivery devices are expected to drive the market.

Every year, approximately 15 million babies around the world are born before the 37th week of pregnancy and this number is expected to increase further. Around 1 million children die each year due to complications caused by preterm births. Premature Rupture of Membranes (PROM) causes about 4.5 million preterm births each year, worldwide. Globally, preterm birth is among the most frequent causes of death among neonates within the first month of life.

Increasing average age of pregnant women (>35 years of age) has led to an increase in the risk of heath conditions such as high blood pressure and reduced blood flow to the placenta. These issues risk the health of both mother and unborn child and often result in preterm births or neonatal deaths. Even though traditional methods such as Nitrazine and Ferning test make it possible to obtain a negative predictive value (NPV), they have extremely poor positive predictive values for spontaneous deliver. The approval of PartaSure (Parsagen Diagnostics, Inc. and Qiagen) in April 2018 and other improved diagnostic test kits has introduced a highly efficacious yet cost-effective options for PROM testing in symptomatic patients.

Further key findings from the report suggest:

• Based on test type, the PAMG1 immunoassay segment is expected to witness lucrative growth over the forecast period driven by rapid uptake of these test kits in developed markets

• Improved PROM diagnostic methods are increasingly replacing traditional standard-of-care tests (Ferning and Nitrazine), supported by their ease of use and high sensitivity

• North America dominated the market with the largest share in 2017. Focus on early diagnosis of women's health issues, along with improved awareness about preterm birth and PROM testing, are responsible for the dominance of this region

• Strong unmet needs, rising awareness regarding maternal health, and uptake of improved diagnostic methods are expected to propel the growth of the preterm labor and PROM testing market

• Some of the key players in the market are Qiagen, Hologic, Cooper Surgical, Abbott Laboratories, Medixbiochemica, Sera Prognostics, Biosynex, and IQ Products.

 Table of Contents

Chapter 1 Methodology and Scope
                 1.1 Research Methodology
                     1.1.1 Information procurement
                 1.2 Information or Data Analysis
                 1.3 Research Scope and Assumptions
                 1.4 List to Data Sources

Chapter 2 Executive Summary
                 2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope
                 3.1 Market Segmentation

Chapter 4 Industry Outlook
                 4.1 Market Variable Analysis
                     4.1.1 Increasing average age of pregnant women leading to exponential rise in the number of preterm births
                     4.1.2 Improvement in point-of-care diagnostics
                     4.1.3 Social and economic factors
                 4.2 Market Restraint Analysis
                     4.2.1 Product recalls and adverse effects
                     4.2.2 High cost and unmet needs

Chapter 5 Preterm Birth and PROM Testing Market: Business Environment Analysis
                 5.1 SWOT Analysis; by factor (Political & Legal, Economic and Technological)
                 5.2 Porter's Five Forces Analysis

Chapter 6 Preterm Birth and PROM Testing Market : Type Business Analysis
                 6.1 Preterm Birth and PROM testing: Type Movement Analysis
                 6.2 Pelvic Exam
                     6.2.1 Pelvic exam market estimates and forecast, 2014 - 2025
                 6.3 Ultrasound
                     6.3.1 Ultrasound market estimates and forecast, 2014 - 2025
                 6.4 Biochemical Markers
                     6.4.1 Biochemical markers market estimates and forecast, 2014 - 2025
                     6.4.2 Interleukin (IL)-6
                         6.4.2.1 Interleukin (IL)-6 market estimates and forecast, 2014 - 2025
                     6.4.3 C-Reactive Protein
                         6.4.3.1 C-Reactive Protein market estimates and forecast, 2014 - 2025
                     6.4.4 IL-1, IL-2, IL-8, and Tumor Necrosis Factor-?
                         6.4.4.1 IL-1, IL-2, IL-8, and Tumor Necrosis Factor-? market estimates and forecast, 2014 - 2025
                     6.4.5 Corticotropin-Releasing Hormone
                         6.4.5.1 Corticotropin-Releasing Hormone market estimates and forecast, 2014 - 2025
                     6.4.6 Fetoprotein
                         6.4.6.1 Fetoprotein market estimates and forecast, 2014 - 2025
                 6.5 Uterine Monitoring
                     6.5.1 Uterine Monitoring market estimates and forecast, 2014 - 2025
                 6.6 Others
                     6.6.1 Others market estimates and forecast, 2014 - 2025
                 6.7 Nitrazine
                     6.7.1 Nitrazine market estimates and forecast, 2014 - 2025
                 6.8 Ferning Test
                     6.8.1 Ferning Test market estimates and forecast, 2014 - 2025
                 6.9 Pooling
                     6.9.1 Pooling market estimates and forecast, 2014 - 2025
                 6.10 Placental alpha-microglobulin-1
                     6.10.1 Placental Alpha-Microglobulin-1, market estimates and forecast, 2014 - 2025
                 6.11 Insulin-Like Growth Factor Binding Protein-1
                     6.11.1 Insulin-Like Growth Factor Binding Protein-1 market estimates and forecast, 2014 - 2025
                 6.12 Fetal Fibronectin
                     6.12.1 Fetal Fibronectin market estimates and forecast, 2014 - 2025

Chapter 7 Preterm Birth and PROM Testing Market: Regional Business Analysis
                 7.1 Preterm Birth and PROM Testing Market: Regional Movement Analysis
                 7.2 North America
                     7.2.1 North America market estimates and forecast, 2014 - 2025
                     7.2.2 U.S.
                         7.2.2.1 U.S. market estimates and forecast, 2014 - 2025
                     7.2.3 Canada
                         7.2.3.1 Canada market estimates and forecast, 2014 - 2025
                 7.3 Europe
                     7.3.1 Europe market estimates and forecast, 2014 - 2025
                     7.3.2 Germany
                         7.3.2.1 Germany market estimates and forecast, 2014 - 2025
                     7.3.3 U.K.
                         7.3.3.1 U.K. market estimates and forecast, 2014 - 2025
                     7.3.4 France
                         7.3.4.1 France market estimates and forecast, 2014 - 2025
                     7.3.5 Italy
                         7.3.5.1 Italy market estimates and forecast, 2014 - 2025
                     7.3.6 Greece
                         7.3.6.1 Greece market estimates and forecast, 2014 - 2025
                     7.3.7 Denmark
                         7.3.7.1 Denmark. market estimates and forecast, 2014 - 2025
                     7.3.8 Spain
                         7.3.8.1 Spain market estimates and forecast, 2014 - 2025
                     7.3.9 Austria
                         7.3.9.1 Austria market estimates and forecast, 2014 - 2025
                     7.3.10 Switzerland
                         7.3.10.1 Switzerland market estimates and forecast, 2014 - 2025
                     7.3.11 Russia
                         7.3.11.1 Russia market estimates and forecast, 2014 - 2025
                 7.4 Asia Pacific
                     7.4.1 Asia Pacific market estimates and forecast, 2014 - 2025
                     7.4.2 Japan
                         7.4.2.1 Japan market estimates and forecast, 2014 - 2025
                     7.4.3 China
                         7.4.3.1 China market estimates and forecast, 2014 - 2025
                     7.4.4 India.
                         7.4.4.1 India market estimates and forecast, 2014 - 2025
                     7.4.5 Australia
                         7.4.5.1 Australia market estimates and forecast, 2014 - 2025
                     7.4.6 Singapore
                         7.4.6.1 Singapore market estimates and forecast, 2014 - 2025
                     7.4.7 South Korea
                         7.4.7.1 South Korea market estimates and forecast, 2014 - 2025
                     7.4.8 Thailand
                         7.4.8.1 Thailand market estimates and forecast, 2014 - 2025
                 7.5 Latin America
                     7.5.1 Brazil
                         7.5.1.1 Brazil market estimates and forecast, 2014 - 2025
                     7.5.2 Mexico
                         7.5.2.1 Mexico market estimates and forecast, 2014 - 2025
                     7.5.3 Argentina
                         7.5.3.1 Argentina market estimates and forecast, 2014 - 2025
                 7.6 Middle East & Africa
                     7.6.1 Middle-East And Africa market estimates and forecast, 2014 - 2025
                     7.6.2 Saudi Arabia
                         7.6.2.1 Saudi Arabia market estimates and forecast, 2014 - 2025
                     7.6.3 South Africa
                         7.6.3.1 South Africa market estimates and forecast, 2014 - 2025
                     7.6.4 Turkey
                         7.6.4.1 Turkey Market Estimates And Forecast, 2014 - 2025
                     7.6.5 Iran
                         7.6.5.1 Iran market estimates and forecast, 2014 - 2025
                     7.6.6 UAE
                         7.6.6.1 UAE market estimates and forecast, 2014 - 2025

Chapter 8 Company Profile
                 8.1 Qiagen Sciences, LLC.
                     8.1.1 Company overview
                     8.1.2 Financial performance
                     8.1.3 Product benchmarking
                     8.1.4 Strategic initiatives
                 8.2 Hologic
                     8.2.1 Company overview
                     8.2.2 Financial performance
                     8.2.3 Product benchmarking
                     8.2.4 Strategic initiatives
                 8.3 Cooper Surgical
                     8.3.1 Company overview
                     8.3.2 Financial performance
                     8.3.3 Product benchmarking
                     8.3.4 Strategic initiatives
                 8.4 Abbott
                     8.4.1 Company overview
                     8.4.2 Financial performance
                     8.4.3 Product benchmarking
                     8.4.4 Strategic initiatives
                 8.5 Medixbiochemica
                     8.5.1 Company overview
                     8.5.2 Financial performance
                     8.5.3 Product Benchmarking
                 8.6 Sera prognostics
                     8.6.1 Company overview
                     8.6.2 Financial performance
                     8.6.3 Product benchmarking
                 8.7 Clinical Innovations, LLC
                     8.7.1 Company overview
                     8.7.2 Financial performance
                     8.7.3 Product benchmarking
                     8.7.4 Strategic initiatives
                 8.8 Biosynex
                     8.8.1 Company overview
                     8.8.2 Financial performance
                     8.8.3 Product benchmarking
                 8.9 NX prenatal
                     8.9.1 Company overview
                     8.9.2 Financial performance
                     8.9.3 Product benchmarking
                     8.9.4 Strategic initiatives
                 8.10 IQ Products
                     8.10.1 Company overview
                     8.10.2 Financial performance
                     8.10.3 Product benchmarking

List of Tables

Table 1 List of Abbreviation
Table 2 North America Preterm birth and PROM testing market, by region, 2014 - 2025 (USD Million)
Table 3 North America Preterm birth and PROM testing market, by test type, 2014 - 2025 (USD Million)
Table 4 U.S. Preterm birth and PROM testing market, by test type, 2014 - 2025 (USD Million)
Table 5 Canada Preterm birth and PROM testing market, by test type, 2014 - 2025 (USD Million)
Table 6 Europe Preterm birth and PROM testing market, by region, 2014 - 2025 (USD Million)
Table 7 Europe Preterm birth and PROM testing market, by test type, 2014 - 2025 (USD Million)
Table 8 U.K. Preterm birth and PROM testing market, by test type, 2014 - 2025 (USD Million)
Table 9 Germany Preterm birth and PROM testing market, by test type, 2014 - 2025 (USD Million)
Table 10 France Preterm birth and PROM testing market, by test type 2014 - 2025 (USD Million)
Table 11 Italy Preterm birth and PROM testing market, by test type 2014 - 2025 (USD Million)
Table 12 Spain Preterm birth and PROM testing market, by test type 2014 - 2025 (USD Million)
Table 13 Greece Preterm birth and PROM testing market, by test type 2014 - 2025 (USD Million)
Table 14 Denmark Preterm birth and PROM testing market, by test type 2014 - 2025 (USD Million)
Table 15 Austria Preterm birth and PROM testing market, by test type 2014 - 2025 (USD Million)
Table 16 Switzerland Preterm birth and PROM testing market, by test type 2014 - 2025 (USD Million)
Table 17 Russia Preterm birth and PROM testing market, by test type 2014 - 2025 (USD Million)
Table 18 Asia Pacific Preterm birth and PROM testing market, by region, 2014 - 2025 (USD Million)
Table 19 Asia Pacific Preterm birth and PROM testing market, by test type, 2014 - 2025 (USD Million)
Table 20 Japan Preterm birth and PROM testing market, by test type, 2014 - 2025 (USD Million)
Table 21 China Preterm birth and PROM testing market, by test type, 2014 - 2025 (USD Million)
Table 22 India Preterm birth and PROM testing market, by test type, 2014 - 2025 (USD Million)
Table 23 South Korea Preterm birth and PROM testing market, by test type, 2014 - 2025 (USD Million)
Table 24 Australia Preterm birth and PROM testing market, by test type, 2014 - 2025 (USD Million)
Table 25 Singapore Preterm birth and PROM testing market, by test type, 2014 - 2025 (USD Million)
Table 26 Thailand Preterm birth and PROM testing market, by test type, 2014 - 2025 (USD Million)
Table 27 Latin america Preterm birth and PROM testing market, by region, 2014 - 2025 (USD Million)
Table 28 Latin america Preterm birth and PROM testing market, by test type, 2014 - 2025 (USD Million)
Table 29 Brazil Preterm birth and PROM testing market, by test type, 2014 - 2025 (USD Million)
Table 30 Mexico Preterm birth and PROM testing market, by test type, 2014 - 2025 (USD Million)
Table 31 Argentina Preterm birth and PROM testing market, by test type 2014 - 2025 (USD Million)
Table 32 MEA Preterm birth and PROM testing market, by region, 2014 - 2025 (USD Million)
Table 33 MEA Preterm birth and PROM testing market, by test type, 2014 - 2025 (USD Million)
Table 34 South Africa Preterm birth and PROM testing market, by test type, 2014 - 2025 (USD Million)
Table 35 Saudi Arabia Preterm birth and PROM testing market, by test type, 2014 - 2025 (USD Million)
Table 36 Turkey Preterm birth and PROM testing market, by test type2014 - 2025 (USD Million)
Table 37 Iran Preterm birth and PROM testing market, by test type2014 - 2025 (USD Million)
Table 38 UAE Preterm birth and PROM testing market, by test type2014 - 2025 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Preterm birth and PROM testing market snapshot
Fig. 8 Preterm birth and PROM testing market segmentation
Fig. 9 Preterm birth and PROM testing market driver impact
Fig. 10 Average cost of delivery (2015) in USD
Fig. 11 Preterm birth and PROM testing market driver impact
Fig. 12 SWOT Analysis, By Factor (Political & legal Economic and technological)
Fig. 13 Porter's Five Forces Analysis
Fig. 14 Preterm birth and PROM testing: Product outlook and key takeaways
Fig. 15 Preterm birth and PROM testing: Type movement analysis
Fig. 16 Pelvic exam market estimates and forecast, 2014 - 2025
Fig. 17 Ultrasound market estimates and forecast, 2014 - 2025
Fig. 18 Biochemical markers market estimates and forecast, 2014 - 2025
Fig. 19 Interleukin (IL)-6 market estimates and forecast, 2014 - 2025
Fig. 20 C-reactive protein market estimates and forecast, 2014 - 2025
Fig. 21 IL-1, IL-2, IL-8, and tumor necrosis factor-? market estimates and forecast, 2014 - 2025
Fig. 22 Corticotropin-releasing hormone market estimates and forecast, 2014 - 2025
Fig. 23 Fetoprotein market estimates and forecast, 2014 - 2025
Fig. 24 Uterine monitoring market estimates and forecast, 2014 - 2025
Fig. 25 Others market estimates and forecast, 2014 - 2025
Fig. 26 Nitrazine market estimates and forecast, 2014 - 2025
Fig. 27 Ferning market estimates and forecast, 2014 - 2025
Fig. 28 Pooling market estimates and forecast, 2014 - 2025
Fig. 29 placental alpha-microglobulin-1 market estimates and forecast, 2014 - 2025
Fig. 30 Insulin-like growth factor binding protein-1 market estimates and forecast, 2014 - 2025
Fig. 31 fFN market estimates and forecast, 2014 - 2025
Fig. 32 Preterm Birth and PROM Testing market: Regional outlook and key takeaways
Fig. 33 Preterm Birth and PROM Testing Market: Regional Movement Analysis
Fig. 34 North America
Fig. 35 North America market estimates and forecast, 2014 - 2025
Fig. 36 U.S. market estimates and forecast, 2014 - 2025
Fig. 37 Canada market estimates and forecast, 2014 - 2025
Fig. 38 Europe
Fig. 39 Europe market estimates and forecast, 2014 - 2025
Fig. 40 Germany market estimates and forecast, 2014 - 2025
Fig. 41 U.K. market estimates and forecast, 2014 - 2025
Fig. 42 France market estimates and forecast, 2014 - 2025
Fig. 43 Italy market estimates and forecast, 2014 - 2025
Fig. 44 Greece market estimates and forecast, 2014 - 2025
Fig. 45 Denmark. market estimates and forecast, 2014 - 2025
Fig. 46 Spain market estimates and forecast, 2014 - 2025
Fig. 47 Austria market estimates and forecast, 2014 - 2025
Fig. 48 Switzerland market estimates and forecast, 2014 - 2025
Fig. 49 Russia market estimates and forecast, 2014 - 2025
Fig. 50 Asia Pacific
Fig. 51 Asia pacific market estimates and forecast, 2014 - 2025
Fig. 52 Japan market estimates and forecast, 2014 - 2025
Fig. 53 China. market estimates and forecast, 2014 - 2025
Fig. 54 India. market estimates and forecast, 2014 - 2025
Fig. 55 Australia market estimates and forecast, 2014 - 2025
Fig. 56 Singapore. market estimates and forecast, 2014 - 2025
Fig. 57 South Korea. market estimates and forecast, 2014 - 2025
Fig. 58 Thailand market estimates and forecast, 2014 - 2025
Fig. 59 Latin America
Fig. 60 Latin America market estimates and forecast, 2014 - 2025
Fig. 61 Brazil market estimates and forecast, 2014 - 2025
Fig. 62 Mexico market estimates and forecast, 2014 - 2025
Fig. 63 Argentina market estimates and forecast, 2014 - 2025
Fig. 64 Middle East & Africa
Fig. 65 Middle east market estimates and forecast, 2014 - 2025
Fig. 66 Saudi Arabia market estimates and forecast, 2014 - 2025
Fig. 67 South Africa market estimates and forecast, 2014 - 2025
Fig. 68 Turkey market estimates and forecast, 2014 - 2025
Fig. 69 Iran market estimates and forecast, 2014 - 2025
Fig. 70 UAE market estimates and forecast, 2014 - 2025